DARE Logo

Urology


The Urology and Urologic Oncology specialty research group strives to facilitate investigations focused on improving clinical outcomes centered on patient care and how to implement changes in the care of our patients. Current topic areas of interest include: refining prostate cancer screening / detection strategies, utility of prostate MRI in men with prior negative biopsies, predicting response of neoadjuvant chemotherapy for invasive bladder cancer, optimizing clinical care of testicular cancer patients, use of outpatient TURP, impact of a regional kidney stone prevention program.


Physicians Involved in Research

Archana Anantharaman, MD
Sacramento Railyard Medical Center
Bill Bassett, MD
Walnut Creek Medical Center
Jay Belani, MD
San Rafael Medical Center
Dazhi Cen, MD
Sacramento Railyard Med Center
Sarah Chan, MD
Santa Clara Homestead
James Chang, MD
Oakland Medical Center
Vish Gajendran, MD
Roseville Medical Center
Mark Gasparini, MD
South San Francisco Medical Center
Suzanne Generao, MD
Sacramento Medical Center
Andrea Harzstark, MD
Oakland Medical Center
Adam Jung, MD
Walnut Creek Medical Center
Kirk Keene, MD
South Sacramento Medical Center
Eric Kwon, MD
Redwood City Medical Center
Tom Pashalides, MD
South Sacramento
Bhavin Patel, MD
Fresno Medical Center
Joseph Presti, MD
Oakland Medical Center
Krishna Ramaswamy, MD
Oakland Medical Center
Ramin Royai, MD
Walnut Creek Medical Center
Lawrence Matt Scala, MD
Santa Clara Homestead
Eugene Seto, MD
Redwood City Medical Center
Mark St. Lezin, MD
Oakland Medical Center
Eschelle Stapp, MD
Roseville Medical Center
Jared Whitson, MD
South Sacramento Medical Center

Ongoing and Completed Urology Projects, All Funding Mechanisms

Development, Validation and Initial Implementation of the Kaiser Permanente Prostate Cancer Risk Calculator 2.0 in Men with a Prior Negative Biopsy
Joseph Presti, Andrew Avins | DSGP | Ongoing

Improving shared decision making for prostate cancer screening
Joseph Presti, Andy Avins | DSGP | Ongoing

Refining Shared Decision Making in Prostate Cancer Screening and Detection
Joseph Presti | PRP | Ongoing

Changing physician PSA screening behavior in men 70 years of age and older by use of the EMR
Joe Presti, Stacey Alexeef, Brandon Horton, Stephanie Prausnitz, Andy Avins. | PRP | Completed

Development of the Kaiser prostate cancer risk calculator
Joe Presti, Stacey Alexeef, Brandon Horton, Stephanie Prausnitz, Andy Avins. | PRP | Completed

Identify predictors of pathologic complete response to neoadjuvant chemotherapy for muscle invasive bladder cancer.
Andrea Harzstark | CH | Completed

Impact of 2012 USPSTF statement on prostate cancer screening and detection in men under the age of 70 at KPNC
Joe Presti, Stacey Alexeef, Brandon Horton, Stephanie Prausnitz, Andy Avins. " | PRP | Completed

Impact of Metformin use on benign prostatic hyperplasia.
Gene Seto | CH | Completed

Prediction of Postoperative Urinary Retention in a Large Integrated Health System
Langston, Marvin PhD | CH | Completed

Prospective Validation of the Kaiser Permanente Prostate Cancer Risk Calculator
Joe Presti | CH | Completed

Significance of borderline high and high serum calcium levels in high risk kidney stone patients in a community practice. Emphasis on high normal serum calcium levels
Mark Gasparini, Stephen Van Den Eeden | TAP | Completed

Vitamin D Supplementation and Kidney Stone Risk
Gene Seto | CH | Completed

The Significance of High Normal Serum Calcium Levels in Recurrent Calcium Stone Formers 
Mark E. Gasparini, MD ; Stephen K. Van Den Eeden, PhD | TAP |